Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001104659-25-019344
Filing Date
2025-02-28
Accepted
2025-02-28 21:43:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4272
  Complete submission text file 0001104659-25-019344.txt   6028
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 212-339-5600
Baker Brothers Life Sciences LP (Reporting) CIK: 0001363364 (see all company filings)

EIN.: 861125324 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Subject) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37686 | Film No.: 25693453
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)